SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-016700
Filing Date
2023-05-02
Accepted
2023-05-02 16:21:30
Documents
61
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q bmea-20230331.htm   iXBRL 10-Q 2533456
2 EX-31.1 bmea-ex31_1.htm EX-31 21199
3 EX-31.2 bmea-ex31_2.htm EX-31 21209
4 EX-32.1 bmea-ex32_1.htm EX-32 11848
5 EX-32.2 bmea-ex32_2.htm EX-32 11694
  Complete submission text file 0000950170-23-016700.txt   7429160

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bmea-20230331_cal.xml EX-101.CAL 37411
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bmea-20230331_lab.xml EX-101.LAB 389723
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bmea-20230331.xsd EX-101.SCH 41318
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bmea-20230331_def.xml EX-101.DEF 154941
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bmea-20230331_pre.xml EX-101.PRE 274731
55 EXTRACTED XBRL INSTANCE DOCUMENT bmea-20230331_htm.xml XML 1149868
Mailing Address 900 MIDDLEFIELD ROAD 4TH FLOOR REDWOOD CITY CA 94063
Business Address 900 MIDDLEFIELD ROAD 4TH FLOOR REDWOOD CITY CA 94063 (650) 980-9099
Biomea Fusion, Inc. (Filer) CIK: 0001840439 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40335 | Film No.: 23879372
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences